Skip to main content
Clinical Trials/NCT04980924
NCT04980924CompletedNot Applicable

Pulmonary Embolism Registry

Centre Hospitalier Universitaire de Nice1 site in 1 country547 target enrollmentStarted: January 1, 1992Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
547
Locations
1
Primary Endpoint
Reccurence

Study Overview

Brief Summary

This survey will allow to identify PE prognostic, but also long-term complications, i.e. recurrence rate, on-treatment bleedings, deep-vein thrombosis sequella, pulmonary hypertension rate, and chronic pulmonary disease rate without PH. This database should help us identify risk-factors for each event.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 110 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • All pulmonary embolisms hospitalised in Nice hospital.
  • acceptation to enter in the cohorte survey

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Reccurence

Time Frame: 10 years

number of patient with Documented symptomatic pulmonary embolism reccurence

Secondary Outcomes

  • Pulmonary hypertension(10 years)
  • Chronic pulmonary disease without hypertension(10 years)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials